Inventor

SHI JIYE

US13 patents

⚠️ This page may combine multiple inventors who share the name “SHI JIYE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UCB PHARMA SA

5 patents

US9011856B2Apr 21, 2015

Antibodies specific for sclerostin and methods for increasing bone mineralization

UCB PHARMA SA7 citations84

US8992911B2Mar 31, 2015

Antibodies specific for sclerostin and methods for increasing bone mineralization

UCB PHARMA SA7 citations84

US11702468B2Jul 18, 2023

Antibodies specific for sclerostin and methods for increasing bone mineralization

UCB PHARMA SA0 citations62

US9045537B2Jun 2, 2015

Antibodies specific to IL-17A and IL-17F

UCB PHARMA SA1 citations57

US9657095B2May 23, 2017

Antibodies specific for sclerostin and methods for increasing bone mineralization

UCB PHARMA SA0 citations52

CELLTECH R & D INC

3 patents

US7381409B2Jun 3, 2008

Antibodies specific for sclerostin and methods of screening and use therefor

CELLTECH R & D INC68 citations98

US7578999B2Aug 25, 2009

Antibodies specific for sclerostin

CELLTECH R & D INC66 citations97

US7985834B2Jul 26, 2011

Compositions and methods for increasing bone mineralization

CELLTECH R & D INC2 citations62

UCB Biopharma SRL

2 patents

US11942188B2Mar 26, 2024

Obtaining an improved therapeutic ligand

UCB Biopharma SRL0 citations52

US12327613B2Jun 10, 2025

De novo antibody design

UCB Biopharma SRL0 citations51

UCB MFG INC

1 patent

US7868134B2Jan 11, 2011

Immunogenic peptides derived from sclerostin

UCB MFG INC49 citations95

WINKLER DAVID G

1 patent

US8563271B2Oct 22, 2013

Antibodies specific for sclerostin and methods for increasing bone mineralization

WINKLER DAVID G7 citations80

UCB BIOPHARMA SPRL

1 patent

US9771420B2Sep 26, 2017

Methods of treating an IL-17A mediated pathological condition

UCB BIOPHARMA SPRL1 citations57